Loading...

Janus Henderson Global Life Sciences Fund Class C

JFNCX•NASDAQ
Financial Services
Asset Management - Global
$55.25
$0.09(0.16%)

Janus Henderson Global Life Sciences Fund Class C (JFNCX) Stock Overview

Explore Janus Henderson Global Life Sciences Fund Class C’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.6/100

Key Financials

Market Cap4.4B
P/E RatioN/A
EPS (TTM)N/A
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Week$55.65
1 Month$56.45
3 Months$58.18
1 Year Target$67.10

JFNCX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Janus Henderson Global Life Sciences Fund Class C (JFNCX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $67.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 4.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for JFNCXStats details for JFNCX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for JFNCXAnalyst Recommendations details for JFNCX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio managers believe have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

Headquarters

Janus Investment Fund, MA

Founded

2009

Frequently Asked Questions

;